People · Operator
Named in public records as an officer, director or promoter · active 2013–2013 · Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Melior Discovery, Inc | — | Pharmaceuticals | Seed | $2.8M | $66.3M | 2013 |
Robert Imershein at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Robert Imershein on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Robert Adelson | 1 | 5 |
| Robert S. Adelson | 1 | 3 |
| JOHN FARAH | 1 | 3 |
| Bobba Venkatadri | 1 | 2 |
| Michael Saporito | 1 | 2 |
| Andrew Reaume | 1 | 2 |
| Toby Moskovits | 1 | 2 |
| Jeffrey Handler | 1 | 1 |
| Donald Marvin | 1 | 1 |
| Jeffry Vaught | 1 | 1 |
| Michael Sapporito | 1 | 1 |
| Toby Moskowitz | 1 | 1 |
| Michael S. Saporito | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.